The tumor microenvironment modulation market is poised for growth driven by increasing focus on advanced immunotherapies, tumor biology understanding, and combination cancer treatments. Expansion is ...

Optical interconnects, leveraging intrinsic advantages such as high bandwidth, low loss, and immunity to electromagnetic interference (EMI), are thus regarded as a promising solution to these barriers ...

Wi-Fi standards remain as confusing as ever.

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...

IBS nano-medicine leader wins Korea’s Top Scientist-Technologist Award for breakthroughs in neural circuit control and ...

Akai Professional has launched the MPC One G2 and MPC Key 37 G2, both running an 8-core processor with 4GB RAM and 64GB internal storage for four times the processing power of their predecessors Both ...

Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help ...

A new approach for identifying signs of hidden awareness in people who cannot speak or move after severe brain injury has ...

Alzheimer's disease (AD) is a devastating neurodegenerative disorder heavily characterized by amyloid-beta (Aβ) plaques, ...

Immune checkpoint blockade (ICB) has reshaped the treatment landscape for advanced hepatocellular carcinoma (HCC), offering ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the completion of its ...